Sign up to access all valuation multiples
CLIO Cosmetics Co Ltd is engaged in the manufacturing and distribution of cosmetic products. The company offers a wide range of cosmetic, makeup and skincare products. Its brand portfolio comprises clio, peripera, goodal, healing bird and dermatory.
1997
n/a
LTM Revenue $249M
LTM EBITDA $14.3M
$83.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
CLIO Cosmetics has a last 12-month revenue (LTM) of $249M and a last 12-month EBITDA of $14.3M.
In the most recent fiscal year, CLIO Cosmetics achieved revenue of $251M and an EBITDA of $25.0M.
CLIO Cosmetics expects next 12-month revenue of XXX and NTM EBITDA of XXX
See CLIO Cosmetics valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $249M | XXX | $251M | XXX | XXX | XXX |
| Gross Profit | $123M | XXX | $122M | XXX | XXX | XXX |
| Gross Margin | 49% | XXX | 49% | XXX | XXX | XXX |
| EBITDA | $14.3M | XXX | $25.0M | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 10% | XXX | XXX | XXX |
| EBIT | $14.1M | XXX | $17.6M | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 7% | XXX | XXX | XXX |
| Net Profit | $15.0M | XXX | $19.9M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of September 3, 2025, CLIO Cosmetics's stock price is KRW 13990 (or $10).
CLIO Cosmetics has current market cap of KRW 245B (or $175M), and EV of KRW 117B (or $83.6M).
See CLIO Cosmetics trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $83.6M | $175M | XXX | XXX | XXX | XXX | $0.81 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of September 3, 2025, CLIO Cosmetics has market cap of $175M and EV of $83.6M.
CLIO Cosmetics's trades at 0.3x EV/Revenue multiple, and 3.3x EV/EBITDA.
Equity research analysts estimate CLIO Cosmetics's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
CLIO Cosmetics has a P/E ratio of 11.6x.
See valuation multiples for CLIO Cosmetics and 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $175M | XXX | $175M | XXX | XXX | XXX |
| EV (current) | $83.6M | XXX | $83.6M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 5.8x | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBIT | 5.9x | XXX | 4.8x | XXX | XXX | XXX |
| EV/Gross Profit | 0.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | 11.6x | XXX | 8.8x | XXX | XXX | XXX |
| EV/FCF | 5.1x | XXX | 7.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCLIO Cosmetics's last 12 month revenue growth is 4%
CLIO Cosmetics's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
CLIO Cosmetics's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
CLIO Cosmetics's rule of X is 16% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for CLIO Cosmetics and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Growth | -5% | XXX | -34% | XXX | XXX | XXX |
| Rule of 40 | 16% | XXX | 14% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 28% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 42% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
CLIO Cosmetics acquired XXX companies to date.
Last acquisition by CLIO Cosmetics was XXXXXXXX, XXXXX XXXXX XXXXXX . CLIO Cosmetics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was CLIO Cosmetics founded? | CLIO Cosmetics was founded in 1997. |
| Where is CLIO Cosmetics headquartered? | CLIO Cosmetics is headquartered in South Korea. |
| Is CLIO Cosmetics publicy listed? | Yes, CLIO Cosmetics is a public company listed on KRX. |
| What is the stock symbol of CLIO Cosmetics? | CLIO Cosmetics trades under 237880 ticker. |
| When did CLIO Cosmetics go public? | CLIO Cosmetics went public in 2016. |
| Who are competitors of CLIO Cosmetics? | Similar companies to CLIO Cosmetics include e.g. Acme United, EZZ Life Science, Lavipharm, Sarantis Group. |
| What is the current market cap of CLIO Cosmetics? | CLIO Cosmetics's current market cap is $175M |
| What is the current revenue of CLIO Cosmetics? | CLIO Cosmetics's last 12 months revenue is $249M. |
| What is the current revenue growth of CLIO Cosmetics? | CLIO Cosmetics revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of CLIO Cosmetics? | Current revenue multiple of CLIO Cosmetics is 0.3x. |
| Is CLIO Cosmetics profitable? | Yes, CLIO Cosmetics is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of CLIO Cosmetics? | CLIO Cosmetics's last 12 months EBITDA is $14.3M. |
| What is CLIO Cosmetics's EBITDA margin? | CLIO Cosmetics's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of CLIO Cosmetics? | Current EBITDA multiple of CLIO Cosmetics is 5.8x. |
| What is the current FCF of CLIO Cosmetics? | CLIO Cosmetics's last 12 months FCF is $16.4M. |
| What is CLIO Cosmetics's FCF margin? | CLIO Cosmetics's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of CLIO Cosmetics? | Current FCF multiple of CLIO Cosmetics is 5.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
